[go: up one dir, main page]

TR201819189T4 - Noktüri İle Bozulmayan İlk Uyku Periyodunun Arttırılması İçin Ağızda Dağılan Desmopressin - Google Patents

Noktüri İle Bozulmayan İlk Uyku Periyodunun Arttırılması İçin Ağızda Dağılan Desmopressin Download PDF

Info

Publication number
TR201819189T4
TR201819189T4 TR2018/19189T TR201819189T TR201819189T4 TR 201819189 T4 TR201819189 T4 TR 201819189T4 TR 2018/19189 T TR2018/19189 T TR 2018/19189T TR 201819189 T TR201819189 T TR 201819189T TR 201819189 T4 TR201819189 T4 TR 201819189T4
Authority
TR
Turkey
Prior art keywords
desmopressin
nocturia
disrupt
dispersed
mouth
Prior art date
Application number
TR2018/19189T
Other languages
English (en)
Inventor
Mirner Klein Bjarke
Peter Norgaard Jens
Shumel Brad
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201819189(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of TR201819189T4 publication Critical patent/TR201819189T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

İhtiyaç duyan bir hastada, bozulmamış bir ilk uyku periyodunun arttırılması dahil kullanımlar için ağızda dağılan bir desmopressin dozu.
TR2018/19189T 2008-05-21 2009-05-21 Noktüri İle Bozulmayan İlk Uyku Periyodunun Arttırılması İçin Ağızda Dağılan Desmopressin TR201819189T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21

Publications (1)

Publication Number Publication Date
TR201819189T4 true TR201819189T4 (tr) 2019-01-21

Family

ID=41100519

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2018/07224T TR201807224T4 (tr) 2008-05-21 2009-05-21 Noktüri ile bozulmayan ilk uyku periyodunun arttırılması için ağızda dağılan desmopressin.
TR2018/19189T TR201819189T4 (tr) 2008-05-21 2009-05-21 Noktüri İle Bozulmayan İlk Uyku Periyodunun Arttırılması İçin Ağızda Dağılan Desmopressin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2018/07224T TR201807224T4 (tr) 2008-05-21 2009-05-21 Noktüri ile bozulmayan ilk uyku periyodunun arttırılması için ağızda dağılan desmopressin.

Country Status (16)

Country Link
US (2) US9974826B2 (tr)
EP (5) EP3085381B1 (tr)
JP (5) JP5767103B2 (tr)
CA (1) CA2724653A1 (tr)
DK (5) DK2296686T4 (tr)
ES (5) ES2677548T3 (tr)
HR (4) HRP20161066T1 (tr)
HU (5) HUE030409T2 (tr)
LT (5) LT3085381T (tr)
LU (1) LUC00015I2 (tr)
NO (3) NO2296686T3 (tr)
PL (5) PL3085381T3 (tr)
PT (5) PT3225249T (tr)
SI (4) SI3225249T1 (tr)
TR (2) TR201807224T4 (tr)
WO (1) WO2009143356A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
SI3225249T1 (sl) * 2008-05-21 2019-02-28 Ferring B.V. Orodisperzibilen dezmopresin za povečanje začetnega obdobja spanja, ki ga ne moti nokturija
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
JP7517993B2 (ja) * 2018-10-16 2024-07-17 日本ケミファ株式会社 睡眠の質の改善剤
AU2019361808A1 (en) * 2018-10-17 2021-05-20 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for nocturnal polyuria
CA3175207A1 (en) * 2020-04-14 2021-10-21 Satomi Yamasaki Sleep quality improver
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE3275121D1 (en) 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
TW279133B (tr) 1990-12-13 1996-06-21 Elan Med Tech
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9101022D0 (sv) 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
IL102857A (en) 1991-08-26 1997-02-18 Abbott Lab Compositions for the sublingual or buccal administration of therapeutic agents which are degraded upon oral administration
DE69227467T2 (de) 1991-12-24 1999-04-22 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo Intrabukkal desintegrierende zubereitung und ihre herstellung
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
PT710243E (pt) 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
DK0708657T3 (da) 1993-06-29 2001-10-15 Ferring Bv Sammensætninger til nasal administration af desmopression
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
JPH09510182A (ja) 1993-11-17 1997-10-14 エルディーエス・テクノロジーズ・インコーポレーテッド カプセル封入されたドラッグデリバリー用透明液
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
DE19518932C2 (de) 1994-05-23 1999-03-18 Samsung Electro Mech Vorrichtung zur Perforation der Haut für die Vorbereitung einer transdermalen Medikation
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
EP0914178B1 (en) 1996-06-18 2003-03-12 Alza Corporation Device for enhancing transdermal agent delivery or sampling
US5763398A (en) 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US6511974B1 (en) 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5932745A (en) 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US6090803A (en) 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6344451B1 (en) 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
AU2462200A (en) 1999-02-15 2000-08-29 Sumitomo Pharmaceuticals Company, Limited Tablets quickly disintegrated in the oral cavity
CA2362814A1 (en) 1999-02-18 2000-08-24 Biovalve Technologies, Inc. Electroactive pore
AR014640A1 (es) 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1296730B2 (en) 2000-01-07 2014-07-30 Valeritas, Inc. Injection device
US20070032410A1 (en) 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
MXPA03003815A (es) 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
ES2574917T3 (es) 2000-11-30 2016-06-23 Valeritas, Inc. Sistemas y procedimientos de suministro y medición de fluido
JP4434583B2 (ja) 2000-11-30 2010-03-17 バイオバルブ テクノロジーズ インコーポレイテッド 注射システム
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
ATE364380T1 (de) 2001-03-16 2007-07-15 Alza Corp Transdermales pflaster zur verabreichung von fentanyl
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
CN1294134C (zh) 2001-04-12 2007-01-10 惠氏公司 环己基苯基血管升压素激动剂
JP2004530668A (ja) 2001-04-12 2004-10-07 ワイス バソプレッシンアゴニストとしてのｎ−ビフェニルカルボニル−およびｎ−フェニルピリジルカルボニル置換二および三環アゼピンおよびジアゼピン
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
WO2003024916A1 (fr) 2001-09-13 2003-03-27 Kissei Pharmaceutical Co., Ltd. Cristaux d'un derive d'hydroxynorephedrine
US6723077B2 (en) 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
ATE438626T1 (de) 2001-11-16 2009-08-15 Astellas Pharma Inc 4,4-difluor-1,2,3,4-tetrahydro-5h-1- benzazepinderivate und deren salze
NZ535861A (en) * 2002-05-07 2006-11-30 Ferring Bv Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
AU2003275301A1 (en) 2002-09-30 2004-04-23 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
US7320984B2 (en) 2002-10-09 2008-01-22 Toray Industries, Inc. Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
ATE512951T1 (de) 2003-04-28 2011-07-15 Astellas Pharma Inc 4,4-difluor-1,2,3,4-tetrahydro-5h-1- benzazepinderivat oder salz davon
US20060193825A1 (en) 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ATE369802T1 (de) 2003-06-30 2007-09-15 Alza Corp Verfahren zum beschichten von mikrovorsprüngen zum durchstechen der haut
DE60301351T2 (de) 2003-07-25 2006-01-19 Ferring B.V. Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US6930932B2 (en) 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
JP2007510445A (ja) 2003-10-24 2007-04-26 アルザ・コーポレーシヨン 経皮薬剤送達促進用の前処置法及びシステム
WO2005041871A2 (en) 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
US7097631B2 (en) 2003-10-31 2006-08-29 Alza Corporation Self-actuating applicator for microprojection array
EP2322197A2 (en) † 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ATE324869T1 (de) 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
DE60303872T2 (de) 2003-12-29 2006-10-19 Ferring B.V. Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
CN1946452A (zh) 2004-01-09 2007-04-11 阿尔扎公司 频率促进的药物透皮释放方法和系统
WO2006029411A2 (en) 2004-09-09 2006-03-16 Yeda Research And Development Co. Ltd. Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
AR056320A1 (es) 2005-04-22 2007-10-03 Wyeth Corp Derivados de cromano y cromeno, procesos de obtencion, composiciones farmaceuticas y usos de los mismos
CN101203218A (zh) 2005-04-22 2008-06-18 惠氏公司 苯并呋喃基链烷胺衍生物和其作为5－ht2c激动剂的用途
BRPI0610046A2 (pt) 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes
CN101203216A (zh) 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
GT200600164A (es) 2005-04-22 2007-03-14 Derivados de dihidrobenzofuranos y usos de los mismos
CA2606064A1 (en) 2005-04-24 2006-11-02 Wyeth Methods for modulating bladder function
EP1893130A4 (en) 2005-06-17 2015-08-26 Georgia Tech Res Inst COATED MICROSTRUCTURES AND METHOD FOR THE PRODUCTION THEREOF
WO2007002523A2 (en) 2005-06-24 2007-01-04 3M Innovative Properties Company Collapsible patch with microneedle array
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
WO2007098945A2 (en) 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
WO2007127976A2 (en) 2006-05-01 2007-11-08 Georgia Tech Research Corporation Particle based molding
CN101801452B (zh) 2007-08-06 2014-10-22 阿勒根公司 用于去氨加压素药物给送的设备
SI3225249T1 (sl) * 2008-05-21 2019-02-28 Ferring B.V. Orodisperzibilen dezmopresin za povečanje začetnega obdobja spanja, ki ga ne moti nokturija

Also Published As

Publication number Publication date
PL2296686T3 (pl) 2014-07-31
JP2016196514A (ja) 2016-11-24
DK2296686T3 (da) 2014-05-12
ES2756706T3 (es) 2020-04-27
LT3225249T (lt) 2019-01-10
ES2710454T3 (es) 2019-04-25
DK3085381T3 (en) 2018-05-28
SI2712622T1 (sl) 2016-10-28
ES2462465T3 (es) 2014-05-22
HRP20191854T1 (hr) 2019-12-27
TR201807224T4 (tr) 2018-06-21
NO2296686T3 (tr) 2014-07-12
JP2015120761A (ja) 2015-07-02
EP3085381B1 (en) 2018-04-18
PL3225250T3 (pl) 2020-02-28
ES2596435T3 (es) 2017-01-09
HUS1900024I1 (hu) 2019-05-28
SI3225249T1 (sl) 2019-02-28
DK2296686T4 (en) 2018-01-02
EP3225249B1 (en) 2018-11-07
PL3225249T3 (pl) 2019-05-31
HUE046050T2 (hu) 2020-01-28
US9974826B2 (en) 2018-05-22
ES2462465T5 (es) 2018-02-28
US20090291880A1 (en) 2009-11-26
HRP20180774T1 (hr) 2018-08-10
EP2712622A1 (en) 2014-04-02
EP3225249A1 (en) 2017-10-04
HUE039013T4 (hu) 2019-08-28
HRP20190114T1 (hr) 2019-03-08
PL2712622T3 (pl) 2017-01-31
HUE039013T2 (hu) 2018-12-28
NO2019021I1 (no) 2019-04-30
PL3085381T3 (pl) 2018-09-28
ES2677548T3 (es) 2018-08-03
EP2712622B1 (en) 2016-07-13
LUC00015I1 (tr) 2017-04-19
EP2296686B1 (en) 2014-02-12
SI3085381T1 (en) 2018-06-29
EP2296686B2 (en) 2017-11-01
PT3225249T (pt) 2019-01-17
LT3085381T (lt) 2018-06-11
JP6001121B2 (ja) 2016-10-05
JP6258424B2 (ja) 2018-01-10
NO3085381T3 (tr) 2018-09-15
JP6506821B2 (ja) 2019-04-24
HRP20161066T1 (hr) 2016-10-21
JP2018035198A (ja) 2018-03-08
LT2712622T (lt) 2016-09-26
LTC2712622I2 (lt) 2020-02-10
PT2296686E (pt) 2014-05-23
US20180250357A1 (en) 2018-09-06
SI3225250T1 (sl) 2019-11-29
PL2296686T5 (pl) 2018-06-29
LTPA2017001I1 (lt) 2017-02-10
DK3225249T3 (en) 2019-02-25
EP3225250A1 (en) 2017-10-04
EP3225250B1 (en) 2019-08-21
LT3225250T (lt) 2019-11-11
EP3085381A1 (en) 2016-10-26
JP6836618B2 (ja) 2021-03-03
PT2712622T (pt) 2016-10-13
JP2011520980A (ja) 2011-07-21
PT3225250T (pt) 2019-10-15
EP2296686A1 (en) 2011-03-23
HUE030409T2 (en) 2017-05-29
JP2019123739A (ja) 2019-07-25
CA2724653A1 (en) 2009-11-26
PT3085381T (pt) 2018-05-18
DK3225250T3 (da) 2019-11-04
HUE041370T2 (hu) 2019-05-28
WO2009143356A1 (en) 2009-11-26
DK2712622T3 (en) 2016-09-12
LUC00015I2 (tr) 2017-06-19
JP5767103B2 (ja) 2015-08-19

Similar Documents

Publication Publication Date Title
TR201819189T4 (tr) Noktüri İle Bozulmayan İlk Uyku Periyodunun Arttırılması İçin Ağızda Dağılan Desmopressin
AU313704S (en) Cable management device
MY153267A (en) Security device
AU326418S (en) Steamer with cover
AU335932S (en) Loudspeaker
MX341778B (es) Goma de mascar natural incluyendo materiales de celulosa.
AU335410S (en) Animal trap
AU335450S (en) Animal trap
AU332218S (en) Drill bit
AU342300S (en) Nail file
CL2014000138A1 (es) Articulo absorbente de oxigeno que comprende carbono, hierro, pulpa de madera refinada y agua.
AU338318S (en) Latch
AU338333S (en) Striker for latch
AU335877S (en) Motorcycle
AU321309S (en) Reel assembly
BR112012031917A2 (pt) combinação antitumoral compreendendo ombrabulina, um derivado de taxano e um derivado de platina
AU325744S (en) Fire detector
Pu et al. The Institutional Foundation Research to Peformance Management of Chinese University Based on Sociological New Institutionalism Perspective
AU332806S (en) Packer/shim/wedge
AU332890S (en) Solar bollard
HN2010001143A (es) Toalla para llevar puesta
TR201210693U (tr) Bir koltuk arkalığı.
AU323927S (en) Cover for a shoe
AU343331S (en) Plectrum
AU333839S (en) Oestrus detector